Neuronetics

STIM · NASDAQ

$1.98+$0.07 (+3.66%)TodayMarket closed ·
Prev close $1.91

Latest news

  • Press releaseGlobe Newswire

    NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Neuronetics Reports Second Quarter 2026 Financial and Operating Results

  • Press releaseGlobe Newswire

    Neuronetics and Jorey Chernett Announce Shared Vision

  • Press releaseGlobe Newswire

    Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

  • NewsVandana Singh

    Why Is Neuronetics Stock Soaring Monday?

  • News

    Full Transcript: Neuronetics Q1 2026 Earnings Call

  • Press releaseGlobe Newswire

    Neuronetics Reports First Quarter 2026 Financial and Operating Results

  • News

    Earnings Scheduled For May 5, 2026

  • NewsCaroline Ryan

    Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan

  • Press releaseGlobe Newswire

    Neuronetics Comments on Letter from Pointillist Family Office

  • Press releaseGlobe Newswire

    Neuronetics Announces Chief Financial Officer Transition

  • Press releasePRNewswire

    Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business

  • Press releaseGlobe Newswire

    Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

  • Press releaseGlobe Newswire

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

  • News

    Earnings Scheduled For March 17, 2026

  • Press releaseBusiness Wire

    Diality Appoints Peter Donato as Chief Financial Officer

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

  • Press releaseGlobe Newswire

    TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

  • News

    Earnings Scheduled For August 5, 2025

  • Press releaseGlobe Newswire

    Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

  • Press releaseGlobe Newswire

    Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releasePRNewswire

    Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

  • Press releaseGlobe Newswire

    Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

  • NewsAvi Kapoor

    Gold Gains Over 1%; Starbucks Shares Move Higher

  • NewsAvi Kapoor

    Crude Oil Surges 2%; B. Riley Financial Shares Plunge

  • NewsAvi Kapoor

    Dow Dips 150 Points; Monday.com Posts Upbeat Earnings

  • Press releaseGlobe Newswire

    Aetna Policy Update Expands TMS Availability for Adolescents With Depression

  • Press releaseGlobe Newswire

    California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.